en
Scientific article
English

Twice- vs. thrice-weekly moderate hypofractionated radiotherapy for prostate cancer: does overall treatment time matter?

Published inJournal of Cancer Research and Clinical Oncology, vol. 145, no. 6, p. 1581-1588
Publication date2019
Abstract

To evaluate the influence of overall treatment time (OTT) in disease control, acute, and long-term side effects with moderate hypofractionated external beam radiotherapy (RT) for prostate cancer (PCa) delivered either twice- or thrice-a-week.

Keywords
  • Hypofractionation
  • Overall treatment time
  • Prostate cancer
  • Radiotherapy
  • Toxicity
Citation (ISO format)
ACHARD, Verane et al. Twice- vs. thrice-weekly moderate hypofractionated radiotherapy for prostate cancer: does overall treatment time matter? In: Journal of Cancer Research and Clinical Oncology, 2019, vol. 145, n° 6, p. 1581–1588. doi: 10.1007/s00432-019-02893-4
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0171-5216
202views
0downloads

Technical informations

Creation04/28/2020 5:28:00 PM
First validation04/28/2020 5:28:00 PM
Update time03/15/2023 9:51:37 PM
Status update03/15/2023 9:51:36 PM
Last indexation01/17/2024 9:43:26 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack